Epinephrine in schools expansion

Summary#

SB-1078, “Clarifying requirements of possession and administration of epinephrine in schools,” would amend West Virginia’s existing school-epinephrine law, §18-5-22c. Its stated goal is to clarify who may possess and administer epinephrine in schools. The bill is introduced and is not law.

  • Schools may stock any FDA-approved form of epinephrine, not only auto-injectors; stocking remains optional.
  • A nurse or trained, authorized nonmedical school employee may administer epinephrine to a student, staff member, or visitor they believe is having anaphylaxis, even without a known allergy or prior prescription.
  • Trained, authorized school transportation employees may administer it to students or school personnel during travel to or from a school function, subject to limits in the bill.
  • The bill sets out civil, criminal, and professional-discipline immunity for certain people who administer epinephrine in good faith and consistently with their training.
  • County boards must collect and report data on administrations, and the State Board of Education must make rules. The supplied material does not show how much of these requirements is new.

What it means for you#

  • Schools and county boards: A school may stock epinephrine but is not required to do so. If it stocks it, the bill says it must be kept in a secure place accessible only to medical personnel and authorized nonmedical personnel—not students. County boards would have to collect and report incident data under the bill’s text.
  • Nurses and trained school employees: They may administer school-stocked epinephrine to a student, staff member, or visitor they believe is experiencing anaphylaxis. The bill does not require them to administer it.
  • Transportation employees: Trained, authorized employees may administer epinephrine to a student or school employee during transportation to or from a school function. They must defer to a person with a higher degree of medical training or the child’s parent if either is present.
  • Students, staff, and visitors: The bill would allow administration without a known allergy or prior prescription. It does not require schools to stock epinephrine or guarantee that it will be available.
  • Parents: The bill says advance notice is not required and notice must follow administration. It also directs the State Board to set detailed notice rules.
  • People who administer epinephrine: The bill provides immunity from civil liability, criminal liability, and professional discipline when administration is in good faith and consistent with training. The bill also exempts trained, authorized transportation employees from the terms of another school-law section; the supplied material does not explain the scope of that exemption.

Money#

No publicly available information on estimated cost.

  • Schools may face costs for buying, storing, and tracking epinephrine; the bill does not require them to stock it.
  • County boards, the State Superintendent, and the State Board would have data, reporting, or rulemaking duties under the bill’s text. No staffing or cost estimate is provided.
  • County boards may take part in free or discounted drug programs, but the bill does not guarantee that those programs will be available.

What is unclear#

  • The supplied material does not include the current text of §18-5-22c or a clean version showing deletions and additions. I could not verify which requirements are new and which are already in current law.
  • The bill does not specify how training is delivered or how often it must be renewed; it directs the State Board to set training and eligibility rules.
  • The scope of “licensed health care provider” in the prescription provision is not clear from the supplied text.
  • The bill directs the State Board to set storage, notice, documentation, and reporting rules, but those details are not included.
  • No start date, funding source, or estimate of implementation costs is provided. Passage is uncertain because the bill is introduced.

Case for#

  • The bill appears intended to let schools respond when someone has anaphylaxis even if that person has no known allergy or prescription.
  • Allowing FDA-approved forms beyond auto-injectors could give schools more than one option for stocking epinephrine.
  • Allowing trained transportation employees to administer it could extend the response option to travel to and from school functions.
  • The bill directs the State Board to set training, storage, and reporting rules, which could provide consistent requirements across schools.

Case against#

  • Schools may choose not to stock epinephrine, so the authority to administer it does not ensure it will be available in an emergency.
  • The bill permits administration based on a trained person’s belief that someone is experiencing anaphylaxis, including without a known allergy or prescription. The bill leaves key training and selection details to later rules.
  • The immunity provisions are broad, covering civil liability, criminal liability, and professional discipline when conditions are met. The bill does not detail how those conditions would be assessed.
  • The bill adds data and reporting duties, but gives no cost estimate or staffing plan.